Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study
West China Hospital
West China Hospital
Instituto do Cancer do Estado de São Paulo
Fundación de investigación HM
Rezolute
Providence Health & Services
Melanoma and Skin Cancer Trials Limited
National Health Research Institutes, Taiwan
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Melanoma and Skin Cancer Trials Limited
Centre Hospitalier Universitaire Dijon
University Health Network, Toronto
Methodist Health System
M.D. Anderson Cancer Center
University of Wisconsin, Madison
Centre Oscar Lambret
Stanford University
University of California, San Francisco
Huazhong University of Science and Technology
M.D. Anderson Cancer Center
University of California, Davis
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Grupo Espanol de Tumores Neuroendocrinos
University of Michigan Rogel Cancer Center
National Institute of Cardiology, Warsaw, Poland
Columbia University
Emory University
Olivia Newton-John Cancer Research Institute
European Institute of Oncology
Cedars-Sinai Medical Center
University of Florida
Assistance Publique - Hôpitaux de Paris
University of Michigan Rogel Cancer Center
University of Utah
University of Alberta
Institut du Cancer de Montpellier - Val d'Aurelle
Jonsson Comprehensive Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Barbara Ann Karmanos Cancer Institute
University of Nebraska
Shanghai Chest Hospital
University of Washington
IRCCS San Raffaele
University of Washington
Imperial College London
Imperial College London
Imperial College London
Mayo Clinic